Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.51 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.51 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | CETP | P11597 | 3/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 6/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8411261 | 1.00 | CYP4F2 (0.51) | CYP4F2CYP4A11NAAACETPEPHX1 | |
| SCHEMBL16652987 | 1.00 | CYP4F2 (0.51) | CYP4F2CYP4A11NAAACETPEPHX1 | |
| SCHEMBL14697097 | 1.00 | CYP4F2 (0.51) | CYP4F2CYP4A11NAAACETPEPHX1 | |
| SCHEMBL16653040 | 1.00 | CYP4F2 (0.51) | CYP4F2CYP4A11NAAACETPEPHX1 | |
| SCHEMBL27260326 | 0.98 | CYP4F2 (0.53) | CYP4F2CYP4A11NAAACETPEPHX1 | |
| SCHEMBL2737083 | 0.86 | CYP4F2 (0.48) | CYP4F2CYP4A11NAAACETPACHE | |
| SCHEMBL186379 | 0.86 | CYP4F2 (0.48) | CYP4F2CYP4A11NAAACETPACHE | |
| SCHEMBL186860 | 0.86 | CYP4F2 (0.48) | CYP4F2CYP4A11NAAACETPACHE | |
| SCHEMBL3634523 | 0.86 | NAAA (0.43) | NAAAEPHX1ACHETSHRCES2 | |
| SCHEMBL16144365 | 0.86 | CHRM2 (0.53) | CYP4F2CYP4A11TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9534104-B2 | Plasticizer blends and use thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-01-03 | — | — | US | claimed |
| US-20220411672-A1 | ADHESIVE COMPOSITION FOR USE IN ROOFING MATERIALS | SEAL BOND, INC. | 2022-12-29 | — | — | US | disclosed |
| US-20210207007-A1 | ADHESIVE COMPOSITION FOR USE IN ROOFING MATERIALS | SEAL BOND, INC. | 2021-07-08 | — | — | US | disclosed |
| US-11001734-B2 | Adhesive composition for use in roofing materials | SEAL BOND, INC. (US) | 2021-05-11 | — | — | US | disclosed |
| US-20200095478-A1 | Adhesive Composition For Use In Roofing Materials | SEAL BOND, INC. | 2020-03-26 | — | — | US | disclosed |
| US-9771466-B2 | Glycol ether-based cyclohexanoate ester plasticizers and blends therefrom | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-09-26 | — | — | US | disclosed |
| US-20150112008-A1 | Glycol Ether-Based Cyclohexanoate Ester Plasticizers and Blends Therefrom | EXXONMOBIL CHEMICAL PATENTS INC. | 2015-04-23 | — | — | US | disclosed |
| US-20140343204-A1 | Esters, Hydrogenated Derivatives Thereof, and Processes for Producing the Same | EXXONMOBIL CHEMICAL PATENTS INC. | 2014-11-20 | — | — | US | disclosed |
| WO-2013025277-A1 | ESTERS AND THEIR PREPARATION AND USE | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-02-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140343204-A1 | Esters, Hydrogenated Derivatives Thereof, and Processes for Producing the Same | ADH5, HDHD5, ADH1A | CYP4F2 252/4885CYP4A11 374/4885NAAA 326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.